TUMORAD

Welcome to the Brand page for “TUMORAD”, which is offered here for Diagnostic preparations for medical or veterinary purposes; medical diagnostic reagents; x-ray contrast agents for medical purposes; radiological contrast substances for medical purposes; contrast media for use in medical imaging; anti-cancer preparations, compounds for treating cancer; pharmaceutical preparations and products for the treatment of cancer; drug delivery agents in the form of nano-sized carriers that facilitate the delivery of pharmaceutical preparations, chemicals used in medicine and nanomedical applications, chemical reagents for medical purposes and chemical preparations for pharmaceutical or medical purposes, for treating cancer;chemicals used in industry and science; chemical reagents for scientific purposes; chemical reagents for non-medical purposes;scientific and technological services and research and design relating thereto, scientific, laboratory, and medical research in the nature of chemistry and nanoscale discovery research, scientific laboratory services, industrial research in the field of medical technology; medical analysis, quality measurement and analysis for medical practices; medical research services; biotechnology research services; research and development in the area of nano-medicine, cancer treatment and cancer diagnostics;.

Its status is currently believed to be active. Its class is unavailable. “TUMORAD” is believed to be currently owned by “Spago Nanomedical AB”.